,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,7.29375048218713e-05,0.0599546289635782
2,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Down,0.000466655436906549,0.139904554373021
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.000510600563405186,0.139904554373021
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.000870039709091554,0.15816685535461
5,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.000962085494857725,0.15816685535461
6,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.00138207066411357,0.189343680983558
7,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.00194454714058782,0.228345392794742
8,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.00293623209818872,0.271509583640072
9,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.00297273266759202,0.271509583640072
10,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,89,Down,0.00411355343649745,0.328962243044293
11,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.00449219219347607,0.328962243044293
12,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.00491143100692714,0.328962243044293
13,WP_MEVALONATE_PATHWAY,7,Down,0.00520256588756181,0.328962243044293
14,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.00569025740129904,0.334099398847701
15,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.00615997782615233,0.337566784873148
16,WP_CREATINE_PATHWAY,2,Up,0.00719785995354433,0.36979005511334
17,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.00771612783181325,0.373097475161794
18,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.0089543499840946,0.39418151782329
19,WP_COMPLEMENT_ACTIVATION,12,Up,0.00911752432745378,0.39418151782329
20,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0095907911879146,0.39418151782329
21,WP_PROSTAGLANDIN_SIGNALING,19,Down,0.0102078417096594,0.399564089778097
22,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.0114837716296113,0.429075467251841
23,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.0126358820204862,0.432778959201652
24,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.0126358820204862,0.432778959201652
25,WP_HYPERTROPHY_MODEL,13,Down,0.0145822840270016,0.479465498807813
26,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0159871845797549,0.505440989406096
27,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.0176289349118015,0.536703129537069
28,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0201319376496717,0.580940067080386
29,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,14,Down,0.0209102919509298,0.580940067080386
30,WP_MACROPHAGE_MARKERS,8,Up,0.0212021922292112,0.580940067080386
31,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0226102499870899,0.587465705209736
32,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.0228697111517172,0.587465705209736
33,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.02597447192496,0.647000482494458
34,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.0360394187335261,0.811258062459337
35,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.0372739768601561,0.811258062459337
36,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.0404484656439358,0.811258062459337
37,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.0405186213752371,0.811258062459337
38,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0408842569051596,0.811258062459337
39,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.0412335631405542,0.811258062459337
40,WP_GASTRIN_SIGNALING,92,Down,0.0413762788062997,0.811258062459337
41,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0415811678583882,0.811258062459337
42,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.042740383875976,0.811258062459337
43,WP_MONOAMINE_GPCRS,3,Down,0.0428792083688363,0.811258062459337
44,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0465945671387233,0.811258062459337
45,WP_HEART_DEVELOPMENT,16,Down,0.0489250928791269,0.811258062459337
46,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.0499616999459639,0.811258062459337
47,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,12,Down,0.0499845514415482,0.811258062459337
48,WP_TRANSSULFURATION_PATHWAY,8,Up,0.050065117424521,0.811258062459337
49,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0504965348464827,0.811258062459337
50,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.0506188173891986,0.811258062459337
51,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0508318972056419,0.811258062459337
52,WP_ZINC_HOMEOSTASIS,21,Down,0.0513204613721235,0.811258062459337
53,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.0524951893790364,0.814170673010715
54,WP_CCL18_SIGNALING,20,Down,0.0558093625533297,0.835399181706567
55,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.0567188125528403,0.835399181706567
56,WP_SERINE_METABOLISM,5,Up,0.0577428626688701,0.835399181706567
57,WP_GPR40_PATHWAY,7,Up,0.0579291403373167,0.835399181706567
58,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.0618396636737754,0.871363044294543
59,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0629325593846398,0.871363044294543
60,WP_SMALL_LIGAND_GPCRS,7,Down,0.0636356249241906,0.871363044294543
61,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.0665221208617845,0.871363044294543
62,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.0677853813114796,0.871363044294543
63,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.0687822744117897,0.871363044294543
64,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.0690522336472787,0.871363044294543
65,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.0692980622354653,0.871363044294543
66,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.0706880808003613,0.871363044294543
67,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.0710235084765625,0.871363044294543
68,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Down,0.0735795036434094,0.881586677559377
69,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.0747646185350219,0.881586677559377
70,WP_G13_SIGNALING,29,Down,0.075074291276346,0.881586677559377
71,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.0768050131063562,0.883218179252962
72,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.0775451822056984,0.883218179252962
73,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Down,0.078436650955555,0.883218179252962
74,WP_IL19_SIGNALING,20,Down,0.0806036168325833,0.886583039439464
75,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.0812952604007624,0.886583039439464
76,WP_TGFB_SMAD_SIGNALING,7,Down,0.0822339494239285,0.886583039439464
77,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.0836079532513692,0.886583039439464
78,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,20,Up,0.0886291680487789,0.886583039439464
79,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0893039822535774,0.886583039439464
80,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0909595332913198,0.886583039439464
81,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.0914592151014436,0.886583039439464
82,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.0919399690511072,0.886583039439464
83,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.092012065376364,0.886583039439464
84,WP_SPINA_BIFIDA,10,Up,0.0932147380427514,0.886583039439464
85,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.0945470424872269,0.886583039439464
86,WP_SPHINGOLIPID_PATHWAY,19,Down,0.0946545381794142,0.886583039439464
87,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.0965334244233038,0.886583039439464
88,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0994379591515795,0.886583039439464
89,WP_COPPER_HOMEOSTASIS,39,Down,0.100177445290496,0.886583039439464
90,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.102426544075395,0.886583039439464
91,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.103194594151986,0.886583039439464
92,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.104460550076342,0.886583039439464
93,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.109910792941918,0.886583039439464
94,WP_GLYOXYLATE_METABOLISM,5,Down,0.110359114556413,0.886583039439464
95,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.112121627212246,0.886583039439464
96,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.112225598839139,0.886583039439464
97,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.112740014799766,0.886583039439464
98,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.112885343545565,0.886583039439464
99,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.112972836988631,0.886583039439464
100,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.113974617660791,0.886583039439464
101,WP_DOPAMINE_METABOLISM,7,Down,0.114136379080887,0.886583039439464
102,WP_NRF2_PATHWAY,71,Down,0.114750527496352,0.886583039439464
103,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.117394036111266,0.886583039439464
104,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.117539342434614,0.886583039439464
105,WP_NOTCH_SIGNALING_WP268,35,Down,0.119796182874375,0.886583039439464
106,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.119948799464438,0.886583039439464
107,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.120017546888991,0.886583039439464
108,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.120336024864427,0.886583039439464
109,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.120750094821832,0.886583039439464
110,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.120846633508808,0.886583039439464
111,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.120891628051753,0.886583039439464
112,WP_NUCLEAR_RECEPTORS,20,Up,0.121896498738237,0.886583039439464
113,WP_RETINOL_METABOLISM,6,Down,0.122026155001058,0.886583039439464
114,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.122956771893064,0.886583039439464
115,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.131096564548149,0.890000302528111
116,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.131214821825557,0.890000302528111
117,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Down,0.131824265194234,0.890000302528111
118,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.132232460019832,0.890000302528111
119,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.134143271965316,0.890000302528111
120,WP_ONECARBON_METABOLISM,22,Up,0.136192892569837,0.890000302528111
121,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.139033865666146,0.890000302528111
122,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.140694389703606,0.890000302528111
123,WP_CHOLESTEROL_METABOLISM,53,Down,0.141580691640871,0.890000302528111
124,WP_MALE_INFERTILITY,66,Up,0.141794094812016,0.890000302528111
125,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.142338119307805,0.890000302528111
126,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.143397734806477,0.890000302528111
127,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.143406082021506,0.890000302528111
128,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.146323087800202,0.890000302528111
129,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.146920151401048,0.890000302528111
130,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.147250539647522,0.890000302528111
131,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.147640720080165,0.890000302528111
132,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.148143391735794,0.890000302528111
133,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.148314760173231,0.890000302528111
134,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.149421981525059,0.890000302528111
135,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.150551016109338,0.890000302528111
136,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.152251953615255,0.890000302528111
137,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.155083890160836,0.890000302528111
138,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.155319182943952,0.890000302528111
139,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.155503450663555,0.890000302528111
140,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.155503450663555,0.890000302528111
141,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.156187834738141,0.890000302528111
142,WP_FOCAL_ADHESION,117,Down,0.156303948835671,0.890000302528111
143,WP_RANKLRANK_SIGNALING,47,Up,0.156832072285258,0.890000302528111
144,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.156873602115262,0.890000302528111
145,WP_VITAMIN_B12_METABOLISM,22,Up,0.162359212326106,0.890000302528111
146,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.166038361814971,0.890000302528111
147,WP_VEGFAVEGFR2_SIGNALING,334,Down,0.168130003823053,0.890000302528111
148,WP_THERMOGENESIS,74,Down,0.17105640039548,0.890000302528111
149,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.171105808126116,0.890000302528111
150,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Down,0.172132492512933,0.890000302528111
151,WP_IL3_SIGNALING,46,Down,0.172604441449069,0.890000302528111
152,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.173367371277785,0.890000302528111
153,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.173723576459307,0.890000302528111
154,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.174401714770125,0.890000302528111
155,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.174665745904644,0.890000302528111
156,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.174665745904644,0.890000302528111
157,WP_MEASLES_VIRUS_INFECTION,99,Down,0.174979997062698,0.890000302528111
158,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.176729864702825,0.890000302528111
159,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.17687190830708,0.890000302528111
160,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.177000694217218,0.890000302528111
161,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.177073133210496,0.890000302528111
162,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,76,Down,0.177540814780207,0.890000302528111
163,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.177872764317756,0.890000302528111
164,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.178818303735226,0.890000302528111
165,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.180367303680467,0.890000302528111
166,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.180782031927571,0.890000302528111
167,WP_ALLOGRAFT_REJECTION,50,Up,0.181437359169845,0.890000302528111
168,WP_SILDENAFIL_TREATMENT,10,Up,0.181897872049541,0.890000302528111
169,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.186005905564524,0.904715114639284
170,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.188662868868993,0.912240460060662
171,WP_PDGFRBETA_PATHWAY,26,Down,0.190730243603371,0.912342419151551
172,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.19155894269466,0.912342419151551
173,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.1920136721572,0.912342419151551
174,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.196961266820626,0.912555038427574
175,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.198576578770434,0.912555038427574
176,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Up,0.199157177795559,0.912555038427574
177,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.199543346347636,0.912555038427574
178,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.19987338265503,0.912555038427574
179,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.201002473549525,0.912555038427574
180,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.202554905281203,0.912555038427574
181,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.203426601407651,0.912555038427574
182,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.204516573460087,0.912555038427574
183,WP_TAMOXIFEN_METABOLISM,2,Up,0.205257127985564,0.912555038427574
184,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.205683847418762,0.912555038427574
185,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.205815814010653,0.912555038427574
186,WP_GLUTATHIONE_METABOLISM,10,Down,0.207026063521329,0.912555038427574
187,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.20846562195058,0.912555038427574
188,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.209789350667323,0.912555038427574
189,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.210820507914253,0.912555038427574
190,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.211482339482362,0.912555038427574
191,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.212041377542174,0.912555038427574
192,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.213807843082928,0.913882214901872
193,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.216168229425838,0.913882214901872
194,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.21738957518149,0.913882214901872
195,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.217673066683297,0.913882214901872
196,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.217908654648135,0.913882214901872
197,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.220210139501946,0.91664078810232
198,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.220910828159661,0.91664078810232
199,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.223573887740318,0.91664078810232
200,WP_GLIOBLASTOMA_SIGNALING,66,Up,0.224844105580484,0.91664078810232
201,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.225029554588839,0.91664078810232
202,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.225257225300083,0.91664078810232
203,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.22886088733955,0.916833407551172
204,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Down,0.229707339282113,0.916833407551172
205,WP_ATR_SIGNALING,10,Up,0.230558502285313,0.916833407551172
206,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.231843784190206,0.916833407551172
207,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.232253432632559,0.916833407551172
208,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Down,0.232420529569609,0.916833407551172
209,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.234155527866772,0.916833407551172
210,WP_NUCLEAR_RECEPTORS_METAPATHWAY,175,Down,0.235486525967358,0.916833407551172
211,WP_PPARALPHA_PATHWAY,15,Up,0.238137759179185,0.916833407551172
212,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.239228504733078,0.916833407551172
213,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.240217007747087,0.916833407551172
214,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.240838426272611,0.916833407551172
215,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.241510320521386,0.916833407551172
216,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.242402381959898,0.916833407551172
217,WP_DNA_DAMAGE_RESPONSE,58,Up,0.242833871644915,0.916833407551172
218,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.24481371819619,0.916833407551172
219,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.245364854889662,0.916833407551172
220,WP_RETINOBLASTOMA_GENE_IN_CANCER,68,Up,0.245716172672329,0.916833407551172
221,WP_SEROTONIN_AND_ANXIETY,6,Down,0.24649657307641,0.916833407551172
222,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.251842179866311,0.9196712447492
223,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.253152179887111,0.9196712447492
224,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.254976914406563,0.9196712447492
225,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.257379907643837,0.9196712447492
226,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.257830094212937,0.9196712447492
227,WP_DNA_MISMATCH_REPAIR,21,Up,0.259712403046173,0.9196712447492
228,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.259768465306047,0.9196712447492
229,WP_FOLATE_METABOLISM,35,Up,0.26110238128146,0.9196712447492
230,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.261451362151657,0.9196712447492
231,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.26252220890651,0.9196712447492
232,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,54,Down,0.263888602277071,0.9196712447492
233,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.264495299539965,0.9196712447492
234,WP_NRF2ARE_REGULATION,20,Down,0.265726397481211,0.9196712447492
235,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.267011619532598,0.9196712447492
236,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.268034730061765,0.9196712447492
237,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Down,0.268175890568206,0.9196712447492
238,WP_IRINOTECAN_PATHWAY,5,Up,0.270176270022333,0.9196712447492
239,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.270677668324844,0.9196712447492
240,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.271409279779962,0.9196712447492
241,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.273752998698764,0.9196712447492
242,WP_PROLACTIN_SIGNALING,69,Up,0.274970612295405,0.9196712447492
243,WP_DNA_REPLICATION,35,Up,0.275441240034136,0.9196712447492
244,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.276515525538176,0.9196712447492
245,WP_GASTRIC_CANCER_NETWORK_1,16,Down,0.277354865976155,0.9196712447492
246,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.278145073648381,0.9196712447492
247,WP_PURINERGIC_SIGNALING,14,Down,0.279281787174287,0.9196712447492
248,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.280438590826627,0.9196712447492
249,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.282901489612795,0.9196712447492
250,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.283109900066599,0.9196712447492
251,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.283612516313354,0.9196712447492
252,WP_PPAR_SIGNALING,39,Up,0.283675241199866,0.9196712447492
253,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.285729496936829,0.9196712447492
254,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.287356860200246,0.9196712447492
255,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.288650187643195,0.9196712447492
256,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.289733316498056,0.9196712447492
257,WP_HISTONE_MODIFICATIONS,37,Up,0.290342548515913,0.9196712447492
258,WP_ID_SIGNALING,12,Up,0.293354125975031,0.9196712447492
259,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.29392251308026,0.9196712447492
260,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.294176528156176,0.9196712447492
261,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.296163344093281,0.9196712447492
262,WP_NEUROINFLAMMATION,10,Down,0.296551656698187,0.9196712447492
263,WP_CANCER_PATHWAYS,302,Down,0.298296832845812,0.9196712447492
264,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.298766770226061,0.9196712447492
265,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.298859161124218,0.9196712447492
266,WP_SMALL_CELL_LUNG_CANCER,68,Up,0.299546500834742,0.9196712447492
267,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.300056575841557,0.9196712447492
268,WP_IL26_SIGNALING,31,Down,0.300078211566375,0.9196712447492
269,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.300962974254909,0.9196712447492
270,WP_ECTODERM_DIFFERENTIATION,76,Down,0.306102455509535,0.922903952519813
271,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.306404517509583,0.922903952519813
272,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Down,0.308845296053579,0.922903952519813
273,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.309633719695011,0.922903952519813
274,WP_NEPHROTIC_SYNDROME,27,Down,0.310098643404708,0.922903952519813
275,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.311677808212258,0.922903952519813
276,WP_PREIMPLANTATION_EMBRYO,21,Down,0.313272115772222,0.922903952519813
277,WP_LUNG_FIBROSIS,32,Down,0.314437943550555,0.922903952519813
278,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.31520485051924,0.922903952519813
279,WP_KININKALLIKREIN_PATHWAY,2,Down,0.316775875404962,0.922903952519813
280,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.316821996402577,0.922903952519813
281,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.31748423750559,0.922903952519813
282,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.318419400787595,0.922903952519813
283,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.318459113291973,0.922903952519813
284,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Up,0.319109249969465,0.922903952519813
285,WP_ARYLAMINE_METABOLISM,1,Down,0.319984947041541,0.922903952519813
286,WP_NRXN1_DELETION_SYNDROME,2,Up,0.325126198812756,0.932591735793801
287,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.325612929650634,0.932591735793801
288,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.328209276366054,0.93676397629478
289,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.333903824794842,0.939537487226524
290,WP_AGERAGE_PATHWAY,53,Down,0.333996652037316,0.939537487226524
291,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.334525238188258,0.939537487226524
292,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.336918705195598,0.939537487226524
293,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.337229276225473,0.939537487226524
294,WP_PDGF_PATHWAY,36,Down,0.337494819083092,0.939537487226524
295,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.337711660606166,0.939537487226524
296,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.339234627801102,0.939537487226524
297,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.339467924216883,0.939537487226524
298,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.341989272414356,0.943339536659733
299,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Down,0.345829084680413,0.946293939959841
300,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,15,Up,0.346696956250706,0.946293939959841
301,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.34747894441238,0.946293939959841
302,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.347974487385846,0.946293939959841
303,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.349096369161294,0.946293939959841
304,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.352596698893731,0.946293939959841
305,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.353017308970297,0.946293939959841
306,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.355571134705953,0.946293939959841
307,WP_METHYLATION_PATHWAYS,5,Down,0.358320731112995,0.946293939959841
308,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.359775664958394,0.946293939959841
309,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.359991748155195,0.946293939959841
310,WP_GLUCURONIDATION,7,Down,0.361717650699203,0.946293939959841
311,WP_MIRNA_BIOGENESIS,6,Down,0.362028092769298,0.946293939959841
312,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.362430270579747,0.946293939959841
313,WP_CYTOSINE_METHYLATION,7,Down,0.363086109906958,0.946293939959841
314,WP_ATM_SIGNALING,34,Up,0.364052593855933,0.946293939959841
315,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.366182092230281,0.946293939959841
316,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.370651186632988,0.946293939959841
317,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.371607253697576,0.946293939959841
318,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.371793837238618,0.946293939959841
319,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.373929373695677,0.946293939959841
320,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.374010893391571,0.946293939959841
321,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.374086891993863,0.946293939959841
322,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.376680456664306,0.946293939959841
323,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.376758690811247,0.946293939959841
324,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.377392559207993,0.946293939959841
325,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.378295967562022,0.946293939959841
326,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.380678780979291,0.946293939959841
327,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.381487002375218,0.946293939959841
328,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.382015420711569,0.946293939959841
329,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.382690531476898,0.946293939959841
330,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,9,Down,0.382802157087545,0.946293939959841
331,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.383606851286721,0.946293939959841
332,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Down,0.38633349258876,0.946293939959841
333,WP_HEPATITIS_B_INFECTION,115,Down,0.386565394328771,0.946293939959841
334,WP_CELLULAR_PROTEOSTASIS,6,Down,0.388425338457886,0.946293939959841
335,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.389605185582109,0.946293939959841
336,WP_NUCLEOTIDE_GPCRS,5,Down,0.389683505086044,0.946293939959841
337,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.392053285027218,0.946293939959841
338,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.392205957665195,0.946293939959841
339,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.394014008165602,0.946293939959841
340,WP_MATRIX_METALLOPROTEINASES,8,Up,0.394191273214281,0.946293939959841
341,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.394940051698659,0.946293939959841
342,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Down,0.395677046696444,0.946293939959841
343,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.396916253297082,0.946293939959841
344,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.398600226199078,0.946293939959841
345,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.399782393727846,0.946293939959841
346,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.399845418886208,0.946293939959841
347,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.399901544904229,0.946293939959841
348,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.402117233008137,0.946293939959841
349,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.402479241676001,0.946293939959841
350,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.404845617347858,0.946293939959841
351,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.405232327525616,0.946293939959841
352,WP_WNT_SIGNALING_WP363,36,Down,0.407998365265373,0.946293939959841
353,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.40826182854987,0.946293939959841
354,WP_ERBB_SIGNALING,67,Up,0.409320837307069,0.946293939959841
355,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.409365752644932,0.946293939959841
356,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.410178898029967,0.946293939959841
357,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.410981674654092,0.946293939959841
358,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.413046880935227,0.946531421616986
359,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.41366170565312,0.946531421616986
360,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Down,0.414539308737366,0.946531421616986
361,WP_CAMKK2_PATHWAY,29,Down,0.416941163476122,0.946977014698547
362,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.419224428921562,0.946977014698547
363,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.419549769505223,0.946977014698547
364,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.419586120556063,0.946977014698547
365,WP_LUNG_PATHOLOGY_OF_COVID19,13,Up,0.421946232970054,0.946977014698547
366,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.422860849262491,0.946977014698547
367,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.422860849262491,0.946977014698547
368,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.425536703483767,0.946977014698547
369,WP_G_PROTEIN_SIGNALING,61,Down,0.425717375687252,0.946977014698547
370,WP_ACUTE_VIRAL_MYOCARDITIS,64,Down,0.426427223448931,0.946977014698547
371,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.429592527263272,0.946977014698547
372,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.429898422050157,0.946977014698547
373,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.431081465854435,0.946977014698547
374,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Down,0.432057201751042,0.946977014698547
375,WP_PRION_DISEASE_PATHWAY,28,Down,0.433288873418815,0.946977014698547
376,WP_HIPPO_SIGNALING_REGULATION,43,Down,0.439359034613054,0.946977014698547
377,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,79,Down,0.439415458932953,0.946977014698547
378,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Up,0.440297310616362,0.946977014698547
379,WP_IL1_SIGNALING,51,Down,0.441378663229871,0.946977014698547
380,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.441780848137722,0.946977014698547
381,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.442283022449265,0.946977014698547
382,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.442291326261011,0.946977014698547
383,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.44370835869564,0.946977014698547
384,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.443917197708367,0.946977014698547
385,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.444256052863895,0.946977014698547
386,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.444992348236921,0.946977014698547
387,WP_B_CELL_RECEPTOR_SIGNALING,83,Up,0.447909591277561,0.946977014698547
388,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.449019521085922,0.946977014698547
389,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,83,Down,0.450078101273941,0.946977014698547
390,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.450486295127328,0.946977014698547
391,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.451977688935348,0.946977014698547
392,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.452234548094258,0.946977014698547
393,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.453963519655355,0.946977014698547
394,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.454309345557541,0.946977014698547
395,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.455436993815953,0.946977014698547
396,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.457365555896349,0.946977014698547
397,WP_PEPTIDE_GPCRS,13,Down,0.458329534016907,0.946977014698547
398,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.458511985219004,0.946977014698547
399,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Down,0.460514010825304,0.947602140970182
400,WP_IL5_SIGNALING,37,Down,0.463923115656238,0.947602140970182
401,WP_CHEMOKINE_SIGNALING,108,Down,0.464784102532418,0.947602140970182
402,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.466102215576159,0.947602140970182
403,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.466367503506099,0.947602140970182
404,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.467013665937779,0.947602140970182
405,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Down,0.467259692983356,0.947602140970182
406,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.468966177836632,0.947602140970182
407,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.469189867852633,0.947602140970182
408,WP_IL4_SIGNALING,50,Down,0.472127679511266,0.951198413132991
409,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.473714877616681,0.952062663571911
410,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,16,Up,0.476454369902227,0.955232907462514
411,WP_TNFALPHA_SIGNALING,82,Down,0.478732003998271,0.956158065165974
412,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.48036498667052,0.956158065165974
413,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.480658821975856,0.956158065165974
414,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.482068682705091,0.956158065165974
415,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.482814797583629,0.956158065165974
416,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.483895079208084,0.956158065165974
417,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.486452935692808,0.956209432518449
418,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.488500687564777,0.956209432518449
419,WP_IL11_SIGNALING,40,Down,0.489631986595007,0.956209432518449
420,WP_NEURAL_CREST_DIFFERENTIATION,39,Down,0.490543984644574,0.956209432518449
421,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.490874585999531,0.956209432518449
422,WP_WNT_SIGNALING_WP428,58,Down,0.490900706232099,0.956209432518449
423,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.495021142052331,0.961068954239312
424,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Down,0.495733864473806,0.961068954239312
425,WP_IL2_SIGNALING,37,Down,0.497042023754992,0.961337749474361
426,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.499611046217764,0.961776131339918
427,WP_HIPPOYAP_SIGNALING,16,Down,0.499896518619139,0.961776131339918
428,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.500778812911782,0.961776131339918
429,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.503089773749583,0.963473335541808
430,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.504006732704352,0.963473335541808
431,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.505520367697832,0.963890236102368
432,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.506570051090296,0.963890236102368
433,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.509485873276612,0.964869730961001
434,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.51057323536261,0.964869730961001
435,WP_IL7_SIGNALING,23,Down,0.511432952060837,0.964869730961001
436,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.511780051945251,0.964869730961001
437,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,131,Down,0.514262033718127,0.965341658869321
438,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.515450060699906,0.965341658869321
439,WP_FRAGILE_X_SYNDROME,83,Down,0.516500804246008,0.965341658869321
440,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.517144329143367,0.965341658869321
441,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.522821771251338,0.965341658869321
442,WP_BARDETBIEDL_SYNDROME,65,Up,0.523227506340602,0.965341658869321
443,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.527164336384652,0.965341658869321
444,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.529307337788196,0.965341658869321
445,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.53064218746783,0.965341658869321
446,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.531284910674241,0.965341658869321
447,WP_HEME_BIOSYNTHESIS,8,Up,0.531284910674241,0.965341658869321
448,WP_TAR_SYNDROME,43,Up,0.531898412315224,0.965341658869321
449,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.532629207131421,0.965341658869321
450,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.532945912620033,0.965341658869321
451,WP_KIT_RECEPTOR_SIGNALING,49,Up,0.534710838483084,0.965341658869321
452,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.535060404242446,0.965341658869321
453,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.538132017950119,0.965341658869321
454,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.538371262754303,0.965341658869321
455,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.538587366229871,0.965341658869321
456,WP_ENDOTHELIN_PATHWAYS,12,Up,0.538874133334359,0.965341658869321
457,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.541119764289209,0.965341658869321
458,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.541361637478445,0.965341658869321
459,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.54430650194032,0.965341658869321
460,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.544703863631232,0.965341658869321
461,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.548887109058196,0.965341658869321
462,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.550181139340839,0.965341658869321
463,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.550230998406738,0.965341658869321
464,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.551439534009738,0.965341658869321
465,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.554194109022045,0.965341658869321
466,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.556303395236477,0.965341658869321
467,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.556697967783216,0.965341658869321
468,WP_ONCOSTATIN_M_SIGNALING,53,Down,0.556827032989861,0.965341658869321
469,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.557072109978225,0.965341658869321
470,WP_NOTCH_SIGNALING_WP61,49,Down,0.559523285367676,0.965341658869321
471,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.561713468005044,0.965341658869321
472,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.561951907066317,0.965341658869321
473,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.562656444382704,0.965341658869321
474,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Down,0.563529844568629,0.965341658869321
475,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.569114521342575,0.965341658869321
476,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.570298674415573,0.965341658869321
477,WP_IRON_METABOLISM_DISORDERS,10,Up,0.570989732063823,0.965341658869321
478,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.573486063237805,0.965341658869321
479,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.57453058942999,0.965341658869321
480,WP_TP53_NETWORK,16,Up,0.576260085662479,0.965341658869321
481,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.577636290845387,0.965341658869321
482,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.577943287972845,0.965341658869321
483,WP_IDO_METABOLIC_PATHWAY,7,Down,0.579781232450605,0.965341658869321
484,WP_VITAMIN_D_METABOLISM,6,Down,0.581159848665099,0.965341658869321
485,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Down,0.582906611903389,0.965341658869321
486,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.583633616359337,0.965341658869321
487,WP_ALZHEIMERS_DISEASE,183,Down,0.584402346982241,0.965341658869321
488,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.584402346982241,0.965341658869321
489,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.585635204938351,0.965341658869321
490,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.58611885938565,0.965341658869321
491,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.587374265571193,0.965341658869321
492,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.588553051893797,0.965341658869321
493,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.589391256620645,0.965341658869321
494,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.589601670940014,0.965341658869321
495,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.590173371069898,0.965341658869321
496,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.592408833704766,0.965341658869321
497,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.592779938105711,0.965341658869321
498,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.592888888452609,0.965341658869321
499,WP_LEPTIN_SIGNALING,69,Down,0.593446906437604,0.965341658869321
500,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.594418179518979,0.965341658869321
501,WP_IL18_SIGNALING,186,Down,0.597949320926145,0.965341658869321
502,WP_CILIOPATHIES,127,Up,0.598252399063736,0.965341658869321
503,WP_BENZOAPYRENE_METABOLISM,5,Up,0.599251708926883,0.965341658869321
504,WP_NPHP1_DELETION_SYNDROME,10,Down,0.602196461820822,0.965341658869321
505,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.6062340699469,0.965341658869321
506,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.60907814307087,0.965341658869321
507,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.609543833602066,0.965341658869321
508,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.610679598999411,0.965341658869321
509,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.61341981775661,0.965341658869321
510,WP_NETRINUNC5B_SIGNALING,34,Up,0.615485319775815,0.965341658869321
511,WP_VALPROIC_ACID_PATHWAY,9,Down,0.616583193846369,0.965341658869321
512,WP_AUTOPHAGY,27,Up,0.617152487159461,0.965341658869321
513,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.618496607004963,0.965341658869321
514,WP_EGFEGFR_SIGNALING,136,Down,0.618519289922048,0.965341658869321
515,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.619470550254234,0.965341658869321
516,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.619627811887001,0.965341658869321
517,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.62066637428315,0.965341658869321
518,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.623411885781336,0.965341658869321
519,WP_BREAST_CANCER_PATHWAY,87,Down,0.624932813792295,0.965341658869321
520,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.625973258002832,0.965341658869321
521,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.629468130517684,0.965341658869321
522,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.629494645097424,0.965341658869321
523,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Up,0.633683876248937,0.965341658869321
524,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Down,0.634619456860762,0.965341658869321
525,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.635930449131737,0.965341658869321
526,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.636780235538308,0.965341658869321
527,WP_BASE_EXCISION_REPAIR,29,Up,0.637117822876438,0.965341658869321
528,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.637727426612857,0.965341658869321
529,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.63796140074584,0.965341658869321
530,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.641109868995479,0.965341658869321
531,WP_PYRIMIDINE_METABOLISM,71,Up,0.642352892392485,0.965341658869321
532,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.643566999825364,0.965341658869321
533,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.643839650638209,0.965341658869321
534,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.644855362501296,0.965341658869321
535,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.646308776185051,0.965341658869321
536,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.646347497798061,0.965341658869321
537,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.647158638318562,0.965341658869321
538,WP_AXON_GUIDANCE,37,Down,0.64797123722206,0.965341658869321
539,WP_PLEURAL_MESOTHELIOMA,248,Down,0.648413155302499,0.965341658869321
540,WP_ENDOMETRIAL_CANCER,49,Down,0.650870534769451,0.965341658869321
541,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.655293793173708,0.965341658869321
542,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.6560128894288,0.965341658869321
543,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.657113977446884,0.965341658869321
544,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,30,Down,0.659131629038785,0.965341658869321
545,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.65934221182782,0.965341658869321
546,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.660942986292314,0.965341658869321
547,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.664022560111255,0.965341658869321
548,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.664517544584026,0.965341658869321
549,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.665496293939041,0.965341658869321
550,WP_IL9_SIGNALING,15,Down,0.666175590215474,0.965341658869321
551,WP_ENDODERM_DIFFERENTIATION,81,Down,0.666274009872671,0.965341658869321
552,WP_RETT_SYNDROME,31,Up,0.666796837144998,0.965341658869321
553,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.667675748591075,0.965341658869321
554,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Up,0.668047896488242,0.965341658869321
555,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.668215988019494,0.965341658869321
556,WP_ASPIRIN_AND_MIRNAS,8,Down,0.672332739678739,0.965341658869321
557,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.673603936262278,0.965341658869321
558,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.673617915979422,0.965341658869321
559,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.674626297137739,0.965341658869321
560,WP_PARKINSONS_DISEASE_PATHWAY,26,Down,0.677983189559972,0.965341658869321
561,WP_SPINAL_CORD_INJURY,64,Down,0.679644187832751,0.965341658869321
562,WP_TRYPTOPHAN_METABOLISM,18,Up,0.681505200231269,0.965341658869321
563,WP_KALLMANN_SYNDROME,11,Down,0.68172232542473,0.965341658869321
564,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.681939042163431,0.965341658869321
565,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.682410339424152,0.965341658869321
566,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.682806913587739,0.965341658869321
567,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.683573028285563,0.965341658869321
568,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.687257593639027,0.965341658869321
569,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.689863254331815,0.965341658869321
570,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,88,Up,0.690554447738202,0.965341658869321
571,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.690626915017842,0.965341658869321
572,WP_CILIARY_LANDSCAPE,184,Down,0.691212623433839,0.965341658869321
573,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.692531896254193,0.965341658869321
574,WP_ADIPOGENESIS,86,Up,0.693387122166762,0.965341658869321
575,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.694140407834836,0.965341658869321
576,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.694372658818872,0.965341658869321
577,WP_OREXIN_RECEPTOR_PATHWAY,116,Up,0.698395894899635,0.965341658869321
578,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.699718655926739,0.965341658869321
579,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,45,Down,0.699914343833328,0.965341658869321
580,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.700538059680031,0.965341658869321
581,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.700561173830077,0.965341658869321
582,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.700711223710902,0.965341658869321
583,WP_CHOLESTASIS,9,Down,0.701744488488878,0.965341658869321
584,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.701807372528027,0.965341658869321
585,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.701918174308465,0.965341658869321
586,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.706622033214438,0.965341658869321
587,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.706823409902011,0.965341658869321
588,WP_MAPK_CASCADE,30,Up,0.707244086076255,0.965341658869321
589,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.709851305199215,0.965341658869321
590,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.711116553861615,0.965341658869321
591,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.711187955188762,0.965341658869321
592,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.713008672603866,0.965341658869321
593,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.713040835337158,0.965341658869321
594,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.714713168650695,0.965341658869321
595,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.717766609816966,0.965341658869321
596,WP_OSTEOBLAST_SIGNALING,3,Down,0.717957879685736,0.965341658869321
597,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.718036624944724,0.965341658869321
598,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.719015572832476,0.965341658869321
599,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.720594002320148,0.965341658869321
600,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.720633798847327,0.965341658869321
601,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.721066893798795,0.965341658869321
602,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Down,0.721098229532447,0.965341658869321
603,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.721733993145874,0.965341658869321
604,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.723022875676297,0.965341658869321
605,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.724686606660052,0.965341658869321
606,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.725289281583123,0.965341658869321
607,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.725684823235981,0.965341658869321
608,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.727053260847373,0.965341658869321
609,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.727385540357358,0.965341658869321
610,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Down,0.727961177778559,0.965341658869321
611,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.729525166528221,0.965341658869321
612,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.73043116522149,0.965341658869321
613,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.731050906835087,0.965341658869321
614,WP_PROTEASOME_DEGRADATION,57,Down,0.731444139481514,0.965341658869321
615,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.731763135631838,0.965341658869321
616,WP_INSULIN_SIGNALING,128,Up,0.731929917799404,0.965341658869321
617,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.732019560406747,0.965341658869321
618,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.732673267065647,0.965341658869321
619,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.734019125432008,0.965341658869321
620,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.734289057265707,0.965341658869321
621,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.734791612296961,0.965341658869321
622,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.735594042267857,0.965341658869321
623,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.735783284931426,0.965341658869321
624,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.735921052502286,0.965341658869321
625,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Down,0.740133768392474,0.965341658869321
626,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.740223176354367,0.965341658869321
627,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,16,Up,0.740570882000916,0.965341658869321
628,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.740729760277119,0.965341658869321
629,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.740914430657267,0.965341658869321
630,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.741034777063919,0.965341658869321
631,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.741034777063919,0.965341658869321
632,WP_BENZENE_METABOLISM,3,Down,0.744003209315686,0.967675060217554
633,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,65,Up,0.745515821962802,0.968110593449326
634,WP_GPCRS_OTHER,10,Up,0.747867827665135,0.969633051010633
635,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.749213270419532,0.969847729582449
636,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.757822486149588,0.977969349828366
637,WP_SLEEP_REGULATION,11,Down,0.757866758930254,0.977969349828366
638,WP_NAD_METABOLISM,12,Up,0.759433211748095,0.978454702283596
639,WP_IL17_SIGNALING,25,Up,0.760751436209132,0.978482822144342
640,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Up,0.764572401444477,0.978482822144342
641,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.764944510969455,0.978482822144342
642,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,6,Down,0.766472525006804,0.978482822144342
643,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.767909568802489,0.978482822144342
644,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.768099062468758,0.978482822144342
645,WP_CELL_CYCLE,92,Up,0.768405701391882,0.978482822144342
646,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,44,Down,0.769579631103024,0.978482822144342
647,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.7710555307735,0.978482822144342
648,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.772243879630686,0.978482822144342
649,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.772710520778702,0.978482822144342
650,WP_VITAMIN_B12_DISORDERS,9,Down,0.773783369022182,0.978482822144342
651,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,63,Down,0.774929826296796,0.978482822144342
652,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.777543659503138,0.979242007091078
653,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.778144086356755,0.979242007091078
654,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.779104954546916,0.979242007091078
655,WP_KLEEFSTRA_SYNDROME,25,Up,0.782428228012418,0.98191756248276
656,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.787178238243465,0.983948940746247
657,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.788029444892891,0.983948940746247
658,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.789726195367948,0.983948940746247
659,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,73,Down,0.79146288489798,0.983948940746247
660,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.794008877075536,0.983948940746247
661,WP_EICOSANOID_SYNTHESIS,13,Down,0.796424398980796,0.983948940746247
662,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.797001983792932,0.983948940746247
663,WP_HUNGER_AND_SATIETY,2,Up,0.798889393240623,0.983948940746247
664,WP_P38_MAPK_SIGNALING,31,Down,0.80180797974918,0.983948940746247
665,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.801919627526493,0.983948940746247
666,WP_COMPLEMENT_SYSTEM,49,Up,0.803028933303334,0.983948940746247
667,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.803792477987531,0.983948940746247
668,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.804075111509452,0.983948940746247
669,WP_PI3KAKT_SIGNALING,176,Down,0.804075325596593,0.983948940746247
670,WP_JOUBERT_SYNDROME,71,Down,0.805254840184752,0.983948940746247
671,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.806094867574626,0.983948940746247
672,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.806509117118975,0.983948940746247
673,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.808637810886912,0.983948940746247
674,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Down,0.808756352582952,0.983948940746247
675,WP_MELANOMA,53,Up,0.808861361378316,0.983948940746247
676,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.80918428703706,0.983948940746247
677,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.811426881198251,0.985141451463896
678,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.813235992696203,0.985141451463896
679,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.814836611337101,0.985141451463896
680,WP_BDNFTRKB_SIGNALING,26,Up,0.814958864957967,0.985141451463896
681,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.818516716218238,0.987989340281045
682,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.822479131854748,0.991316490300004
683,WP_MRNA_PROCESSING,124,Down,0.827326372093816,0.993487682502367
684,WP_FOXA2_PATHWAY,9,Down,0.82858244122031,0.993487682502367
685,WP_IL6_SIGNALING,38,Down,0.828672038140227,0.993487682502367
686,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.829115024570102,0.993487682502367
687,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.83226354509058,0.995808783208816
688,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.834053957794747,0.996321019526806
689,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.841118605454032,0.996321019526806
690,WP_STEROID_BIOSYNTHESIS,2,Up,0.841923938518823,0.996321019526806
691,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.844283080547066,0.996321019526806
692,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.845425491927829,0.996321019526806
693,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.845648752499446,0.996321019526806
694,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.845754149837166,0.996321019526806
695,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.846050941766356,0.996321019526806
696,WP_BURN_WOUND_HEALING,57,Down,0.849417132704325,0.996321019526806
697,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.851701654204141,0.996321019526806
698,WP_FERROPTOSIS,50,Down,0.853519774629948,0.996321019526806
699,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.854302178527804,0.996321019526806
700,WP_MTHFR_DEFICIENCY,18,Down,0.855283650405445,0.996321019526806
701,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.856231295949984,0.996321019526806
702,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.858030059256154,0.996321019526806
703,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.859289484191725,0.996321019526806
704,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.859372550267246,0.996321019526806
705,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.861854432144348,0.996321019526806
706,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.862913693505028,0.996321019526806
707,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.863023430395625,0.996321019526806
708,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.865473880402813,0.996321019526806
709,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.866077884363975,0.996321019526806
710,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.866358256848035,0.996321019526806
711,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.868064149520825,0.996321019526806
712,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.870064773924018,0.996321019526806
713,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.871135614378025,0.996321019526806
714,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.874752532181469,0.996321019526806
715,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.874867419815338,0.996321019526806
716,WP_CIRCADIAN_RHYTHM_GENES,119,Up,0.877764338798307,0.996321019526806
717,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.879287250122283,0.996321019526806
718,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.879707210129599,0.996321019526806
719,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.880437422489081,0.996321019526806
720,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.882145152103352,0.996321019526806
721,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.883535185683596,0.996321019526806
722,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.885776195969973,0.996321019526806
723,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.88692202875061,0.996321019526806
724,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.888570033217591,0.996321019526806
725,WP_DRAVET_SYNDROME,13,Down,0.889202295024841,0.996321019526806
726,WP_RAS_SIGNALING,114,Down,0.895342485236676,0.996321019526806
727,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.896981108419242,0.996321019526806
728,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.900575246610833,0.996321019526806
729,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.900995303479749,0.996321019526806
730,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.90116898763786,0.996321019526806
731,WP_CORI_CYCLE,11,Up,0.902105837899986,0.996321019526806
732,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.902291792591155,0.996321019526806
733,WP_MAPK_SIGNALING,162,Down,0.902665796428919,0.996321019526806
734,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.902904777974082,0.996321019526806
735,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.90422730483833,0.996321019526806
736,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.907329148551965,0.996321019526806
737,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.907944476553972,0.996321019526806
738,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.908442434579141,0.996321019526806
739,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,37,Up,0.910847378935702,0.996321019526806
740,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.911422603275381,0.996321019526806
741,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.916817722661312,0.996321019526806
742,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.916949307598288,0.996321019526806
743,WP_PURINE_METABOLISM,10,Down,0.919733467390699,0.996321019526806
744,WP_MONOAMINE_TRANSPORT,12,Up,0.919764210457869,0.996321019526806
745,WP_AEROBIC_GLYCOLYSIS,10,Up,0.920626561439123,0.996321019526806
746,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.920626561439123,0.996321019526806
747,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Up,0.9216242328014,0.996321019526806
748,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.92321888207494,0.996321019526806
749,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.926979623156013,0.996321019526806
750,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.928090676147581,0.996321019526806
751,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,17,Down,0.928560912558829,0.996321019526806
752,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.92961391418318,0.996321019526806
753,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Up,0.929623427679242,0.996321019526806
754,WP_NEPHROGENESIS,4,Up,0.930057135027977,0.996321019526806
755,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.930229729466311,0.996321019526806
756,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.930649551673836,0.996321019526806
757,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.930698582595728,0.996321019526806
758,WP_OSTEOPONTIN_SIGNALING,11,Up,0.93262931287921,0.996321019526806
759,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.933462536547312,0.996321019526806
760,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.933954876130151,0.996321019526806
761,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.934541178701247,0.996321019526806
762,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.935440977646029,0.996321019526806
763,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.935704701725591,0.996321019526806
764,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.935857648951571,0.996321019526806
765,WP_OVARIAN_INFERTILITY,20,Down,0.937186891750137,0.996321019526806
766,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.938754300704904,0.996321019526806
767,WP_ESTROGEN_SIGNALING,21,Up,0.940160061584751,0.996321019526806
768,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.941898741269246,0.996321019526806
769,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.942949052017615,0.996321019526806
770,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Up,0.943409361985623,0.996321019526806
771,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,170,Up,0.943847057628538,0.996321019526806
772,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.945486893104358,0.996321019526806
773,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.947552834635028,0.996321019526806
774,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.94855076894229,0.996321019526806
775,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.948984369059803,0.996321019526806
776,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.949510727400839,0.996321019526806
777,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.951642621990205,0.996321019526806
778,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.951892202669597,0.996321019526806
779,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.952314199126123,0.996321019526806
780,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.953504433306671,0.996321019526806
781,WP_AMINO_ACID_METABOLISM,59,Down,0.953704682005996,0.996321019526806
782,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.953910041933258,0.996321019526806
783,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.954311307596407,0.996321019526806
784,WP_ENERGY_METABOLISM,41,Down,0.956477778409971,0.996321019526806
785,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.959655261448655,0.996321019526806
786,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.959980254615492,0.996321019526806
787,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.960604188591315,0.996321019526806
788,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.963885436699009,0.996321019526806
789,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.964295785521907,0.996321019526806
790,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.966114057147184,0.996321019526806
791,WP_TRANSLATION_FACTORS,49,Up,0.966114795297886,0.996321019526806
792,WP_ANGIOGENESIS,13,Up,0.966837876773823,0.996321019526806
793,WP_KREBS_CYCLE_DISORDERS,11,Down,0.967163000447167,0.996321019526806
794,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.968028277592908,0.996321019526806
795,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.968249123564665,0.996321019526806
796,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.969814918221753,0.996321019526806
797,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.971972261401969,0.996321019526806
798,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.9721141990551,0.996321019526806
799,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.972556641923998,0.996321019526806
800,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.972636710860427,0.996321019526806
801,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Down,0.974081811833439,0.996321019526806
802,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.974651354595082,0.996321019526806
803,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.975612771899246,0.996321019526806
804,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.975641840764614,0.996321019526806
805,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.975858294969724,0.996321019526806
806,WP_FOXP3_IN_COVID19,9,Down,0.978992365207459,0.996321019526806
807,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.979312329520824,0.996321019526806
808,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.98020485076936,0.996321019526806
809,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,46,Up,0.980830882156763,0.996321019526806
810,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.983583616635248,0.996321019526806
811,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.985946401019148,0.996321019526806
812,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.986373898082728,0.996321019526806
813,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.986984981075856,0.996321019526806
814,WP_ALSTROM_SYNDROME,27,Up,0.988031609460098,0.996321019526806
815,WP_15Q11Q13_COPY_NUMBER_VARIATION,33,Down,0.988590033222178,0.996321019526806
816,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.98904860332588,0.996321019526806
817,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.990505582208855,0.996567427877208
818,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.991781094765474,0.99663088006995
819,WP_BLADDER_CANCER,29,Up,0.994460636674098,0.997091595693103
820,WP_OSTEOCLAST_SIGNALING,9,Down,0.995525645837021,0.997091595693103
821,WP_APOPTOSIS,71,Up,0.995878588885691,0.997091595693103
822,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.999323201656771,0.999323201656771
